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Throughout ourmedical training, we are taught how tomanage patients who present with symptoms, which usually leads
to a clinical examination, a diagnosis, and a management plan. However, virtually no time is spent on teaching how to
manage patients who have no symptoms because they have lost the ability to feel pain; that is, they have peripheral
neuropathy. The lifetime incidence of foot ulceration in people with diabetes has been estimated to be as high as 25%, and
a number of contributory factors result in a foot being at risk of ulceration. Most important amongst these factors is
peripheral neuropathy, or the loss of the ability to feel pain, temperature, or pressure sensation in the feet and lower legs.
Up to 50% of older patients with type 2 diabetes have evidence of sensory loss that puts them at risk of foot ulceration.
If we are to succeed in reducing the high incidence of foot ulcers, regular screening for peripheral neuropathy is vital in
all patients with diabetes. Those found to have any risk factors for foot ulceration require special education and more
frequent review, particularly with podiatrists. The key message is therefore that neuropathic symptoms correlate poorly
with sensory loss, and their absence must never be equated with lack of risk of foot ulceration. If we are to succeed in
reducing the high incidence of foot ulceration and, particularly, recurrent ulceration, we must realize that with loss of
pain there is also diminished motivation in the healing and the prevention of injury. (J Vasc Surg 2010;52:28S-30S.)Pain is God’s greatest gift to mankind.
—Paul Brand
It was Dr Paul Brand, working with patients suffering
from Hansen’s disease in South India, who recognized that
it was the loss of peripheral sensation in the limbs that
resulted in the terrible scarring and ulceration that occurred
in these individuals. Pain is indeed a gift, but the gift of pain
is only recognized when it is lost as it is a protective
sensation that prevents us from further damaging areas of
injury. In a very similar way to leprosy, patients with sensory
loss secondary to diabetes, which predominates in the lower
limb, frequently develop ulcers and even more serious
conditions, such as Charcot neuroarthropathy, because
they have lost this gift of pain.
A reduction in neuropathic foot problems will only be
achieved if we remember that those with insensitive feet
have lost this warning signal of pain that ordinarily brings
the patients to their doctors. The identification and care of
a patient with no pain sensation is a new challenge for which
most of us have little if any training. It is difficult for us to
understand, for example, that an intelligent patient would
buy and wear a pair of shoes several sizes too small and
come to our clinic with an extensive shoe-induced ulcer.
The explanation, however, is simple: with reduced sensa-
tion, a very tight fit stimulates the remaining pressure nerve
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28Sendings and the individual interprets this as a normal fit;
hence, the common complaint when we provide patients
with custom-designed shoes is “these shoes are too loose.”
We can learn much about the management of patients with
diabetic neuropathy from the treatment of patients with
leprosy.1 If we are to succeed, we must realize that with loss
of pain there is also diminished motivation in the healing of
and the prevention of injury.
Because the lifetime incidence of foot ulceration in
diabetic patients has been estimated to be as high as 25%,2
understanding the pathways that result in the development
of an ulcer is increasingly important. It was the Scottish
poet, Thomas Campbell who wrote, “Coming events cast
their shadows before.” These words can usefully be applied
to the breakdown of the diabetic foot because ulceration
does not spontaneously occur but is caused by a combina-
tion of factors that result in the development of a lesion.
Thus, there are many warning signs or “shadows” that can
identify those at risk.
Other articles in this issue will cover the important area
of peripheral vascular disease in the causation of lower
extremity problems, and in this review I will focus on the
commonest of the diabetic neuropathies, chronic sensori-
motor neuropathy, which is a major contributory factor in
the pathway to ulceration in diabetes. The final section will
discuss simple methods to screen for the high-risk patient of
foot ulcer, which will be based on the recently published
Comprehensive Diabetic Foot Examination by a task force
of the American Diabetes Association.3
CHRONIC SENSORIMOTOR DIABETIC
PERIPHERAL NEUROPATHY
Of all the neuropathies of diabetes, the chronic senso-
rimotor variety, diabetic peripheral neuropathy (DPN), is
by far the commonest. Indeed, it has been estimated that
up to 50% of older type 2 diabetic patients may have
evidence of sensory loss on clinical examination and there-
fore must be considered at risk of insensitive foot injury.4 In
the large United Kingdom Prospective Diabetes Study,
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loss of sufficient severity to put them at risk of insensitive
foot lesions. This provides a clear message: People with any
duration of type 2 diabetes might have significant risk of
developing foot problems.4
DPN commonly results in a sensory loss confirmed on
examination by a deficit in the stocking distribution to all
sensory modalities. Evidence of motor dysfunction in the
form of small muscle wasting is also often present, whereas
some patients might give a history (past or present) of
typical neuropathic symptoms such as burning pain, stab-
bing discomfort, and paraesthesia with nocturnal exacerba-
tion, others might develop sensory loss without ever having
any such history. Some patients might have the “painful-
painless” leg with spontaneous discomfort secondary to
neuropathic symptoms, but who on examination have both
small and large fiber sensory deficits, and these patients are
also at great risk of painless injury to their feet.
From the above, it should be clear that a spectrum of
symptomatic severity may be present, with some patients
experiencing severe pain, and at the other end of the
spectrum, patients who have no spontaneous symptoms;
however, both groups may have significant sensory loss on
clinical examination. The most challenging patients are
indeed those who develop sensory loss with no history of
symptoms. It is often difficult to convince them that they
are at risk of foot ulceration because they feel no discom-
fort, and motivation to perform regular self-foot care is
difficult.
The key message is that neuropathic symptoms correlate
poorly with sensory loss and their absence must never be
equated with lack of foot ulcer risk. Thus, in the assessment
of foot ulcer risk, a careful foot examination after removal of
shoes and socks must always be included whatever the
history of the symptoms.4 Hence the clinical observation,
again by Dr Paul Brand, that any patient who walks into the
clinic with a foot ulcer but without a limp must have
neuropathy because those with normal pain sensation
would not be able to put weight on the lesion.
Most patients with significant risk of foot ulceration
due to sensory loss also have peripheral autonomic dysfunc-
tion affecting the sympathetic nervous system. This results
in reduced sweating and, in the absence of large vessel
obstructive vascular disease, increased blood flow to the
foot with arteriovenous shunting leading to the warm, but
insensate foot.
OTHER RISK FACTORS
The neuropathic insensate foot does not ulcerate spon-
taneously. A combination of factors ultimately results in
breakdown and ulceration. Those factors that increase the
risk of foot ulceration are listed in Table I. The highest-risk
populations are those with a history of previous ulceration or
even amputation. Several studies have shown that patients
with other late complications of diabetes include nephropathy
(particularly those on dialysis or post-transplantation) and
retinopathy (particularly if there is visual loss). There appearsto be a temporal relationship between starting dialysis and
risk of foot ulcers.5
Other important contributory factors to ulcers include
the presence of callus or hard skin under weight-bearing
areas, which occurs as a consequence of pressure plus dry
skin due to autonomic neuropathy, and also foot defor-
mity. A combination of motor neuropathy, limited joint
mobility, and altered gait patterns are thought to result in
the “high-risk” neuropathic foot with clawing of the toes,
prominent metatarsal heads, a high arch, and small-muscle
wasting.
PATHWAY TO ULCERATION
The combination of two or more risk factors ultimately
results in breakdown of the diabetic foot. In a study of
instant foot ulcers, Reiber et al6 showed that the common-
est triad of component causes resulting in ulceration are
neuropathy (loss of pain sensation), foot deformity, and
trauma. Edema and ischemia are among the other impor-
tant component causes in the pathway to ulceration.
SCREENING FOR FOOT ULCERS
Superior doctors prevent the disease: mediocre doctors treat
the disease before evident: inferior doctors treat the full
blown disease.
—Huang DEE, China, 2600 BC.
The Chinese proverb is probably true, and there needs
to be a shift from mostly being inferior doctors to mostly
being superior, and that by preventing foot ulcers by iden-
tifying those at risk, and by foot care education and regular
assessments and treatment, preventing the ulcers from ac-
tually occurring. Many countries have now adopted the
principle of “the annual review,” where every diabetic
patient is screened at least annually for evidence of diabetic
complications. Such a review can be carried out in primary
care or in a hospital diabetic clinic.
A task force of the American Diabetes Association
recently addressed the question of what should be included
for the annual review in the “Comprehensive Diabetic Foot
Examination (CDFE).”3 This group addressed and con-
Table I. Factors increasing risk of diabetic foot
ulceration
● Peripheral neuropathy
– Somatic
– Autonomic
● Peripheral vascular disease
● Past history of foot ulcers or amputation
● Other long-term complications
– End-stage renal disease—on dialysis
– Visual loss—post-transplantation
● Plantar callus
● Foot deformity
● Edema
● Ethnic background
● Poor social backgroundcisely summarized the recent literature in the area and
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icine that should be included in the CDFE for adult pa-
tients with diabetes. The main emphasis of this report was
on a concise clinical examination to identify the patient at
risk. A summary of the key components of the CDFE is
provided in Table II. Whereas each potential simple neu-
rologic clinical assessment has advantages and disadvan-
tages, it was felt that the 10-gauge monofilament had much
evidence to support its use, hence the recommendation
that assessment of neuropathy should always comprise the
use of such a filament plus one other confirmatory test. In
addition to the simple tests listed in Table II, one possible
test that was also included was use of vibration perception
threshold by using a biothesiometer or vibration perception
Table II. Key components of the diabetic foot
examination
Inspection
● Evidence of past/present ulcers?
● Foot shape?
● Prominent metatarsal heads/claw toes
● Hallux valgus
● Muscle wasting
● Charcot deformity
● Dermatologic?
– Callus
– Erythema
– Sweating
Neurologic
● 10-g monofilament at 4 sites on each foot
 1 of the following
Vibration using 128 HZ tuning fork
● Pinprick sensation
● Ankle reflexes
● Vibration perception threshold
Vascular
● Foot pulses
● Ankle brachial index, if indicated
Adapted from Boulton et al.3threshold meter. Although this is a semi-quantitative test ofsensation, it was included because many centers in North
America and Europe have such equipment. As can be seen
from Table II, however, this is not regarded as essential so
these CDFE can be performed with simple clinical tools
that do not require any external power source.
CONCLUSIONS
As can be seen, whereas the neuropathic foot is at great
risk of ulceration, this need not occur and almost all such
ulcers should be entirely preventable. This depends on
realization by the patients themselves that they have risk of
foot ulcers and the application of simple foot self-care such
as regular inspection and podiatric care. However, it re-
mains depressing that there are still reports that many
patients are not receiving regular foot screens: if we as
physicians fail to examine patients’ feet when we occasion-
ally see them, can we honestly expect them to examine their
feet on a daily basis?
REFERENCES
1. Brand PW. Diabetic foot. In: Ellenberg M, Rifkin H, editors. Diabetes
mellitus: theory and practice. 3rd ed. New York: Medical Examination
Publishing; 1983. p. 829-49.
2. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients
with diabetes. JAMA 2005;293:217-28.
3. Boulton AJM, Armstrong DG, Albert SF, Frykberg RG, Hellman R,
Kirkman MS, et al. Comprehensive foot examination and risk assessment:
a report of the Task Force of the Foot Care Interest Group of the
American Diabetes Association, with endorsement by the American
Association of Clinical Endocrinologists and risk assessment: a report of
the task force of the foot care interest group of the American Diabetes
Association, with endorsement by the American Association of Clinical
Endocrinologists. Diabetes Care 2008;31:1679-85.
4. Boulton AJM, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic
neuropathies: technical review. Diabetes Care 2004;27:1458-86.
5. Game FL, Chipchase SY, Hubbard R, Burden RP, Jeffcoate WJ. Tem-
poral association between the incidence of foot ulceration and the start of
dialysis in diabetes mellitus. Nephrol Dial Transplant 2006;21:3207-10.
6. Reiber GE, Vileikyte L, Boyko EJ, del Aguila M, Smith DG, Lavery LA,
et al. Causal pathways for incident lower-extremity ulcers in patients with
diabetes from two settings. Diabetes Care 1999;22:157-62.
